Recombinant PorA, the Major Outer Membrane Protein of Campylobacter jejuni, Provides Heterologous Protection in an Adult Mouse Intestinal Colonization Model

被引:23
作者
Islam, Anjum [1 ]
Raghupathy, Raj [1 ]
Albert, M. John [1 ]
机构
[1] Kuwait Univ, Dept Microbiol, Fac Med, Jabriya, Kuwait
关键词
ESCHERICHIA-COLI; VACCINE; INFECTION; EPITOPES; MUCOSAL; IMMUNOGENICITY; POLYSACCHARIDE; ANTIBODIES; RESISTANCE; CHALLENGE;
D O I
10.1128/CVI.00255-10
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunity against Campylobacter jejuni, a major food-borne pathogen causing diarrhea, is largely serotype specific. The major outer membrane protein (MOMP) of C. jejuni, PorA, is a common antigen with the potential to provide broad protection. Adult BALB/c mice were orally immunized with a recombinant glutathione S-transferase (GST) fused to PorA prepared from Campylobacter jejuni C31 (O:6,7) (GST-PorA) combined with a modified heat-labile enterotoxin of Escherichia coli as an adjuvant and later orally challenged with C31 strain or three heterologous strains: 48 (O: 19), 75 (O: 3), and 111 (O: 1,44). Protection from colonization with the challenge organism was studied by fecal screening daily for 9 days. Serum and intestinal lavage fluid antibodies against the vaccine and Sarkosyl-purified MOMP from C31 were measured by using an enzyme-linked immunosorbent assay. The vaccine produced robust antibody responses against both antigens in serum and secretion. Since strain C31 was a poor colonizer, homologous protection could not be studied. The protective efficacies of heterologous strains were 43% (for strain 48, P < 0.001), 29% (for strain 75, P < 0.005), and 42% (for strain 111, P < 0.001) for the 9-day period compared to control mice given phosphate-buffered saline. Thus, PorA provided appreciable protection against colonization with heterologous serotypes.
引用
收藏
页码:1666 / 1671
页数:6
相关论文
共 45 条
[1]   Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin [J].
Albert, M. John ;
Haridas, Shilpa ;
Adler, Ben .
CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (05) :859-862
[2]   Tetracycline Resistance Is Frequent Among Campylobacter jejuni Isolates from Kuwait [J].
Albert, M. John ;
Udo, Edet ;
Jose, Berneesh T. ;
Haridas, Shilpa ;
Rotimi, Vincent O. .
MICROBIAL DRUG RESISTANCE, 2009, 15 (02) :115-120
[3]   Cholera toxin, E-coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches [J].
Anosova, N. G. ;
Chabot, S. ;
Shreedhar, V. ;
Borawski, J. A. ;
Dickinson, B. L. ;
Neutra, M. R. .
MUCOSAL IMMUNOLOGY, 2008, 1 (01) :59-67
[4]   SAFETY AND IMMUNOGENICITY OF A PROTOTYPE ORAL WHOLE-CELL KILLED CAMPYLOBACTER VACCINE ADMINISTERED WITH A MUCOSAL ADJUVANT IN NONHUMAN-PRIMATES [J].
BAQAR, S ;
BOURGEOIS, AL ;
SCHULTHEISS, PJ ;
WALKER, RI ;
ROLLINS, DM ;
HABERBERGER, RL ;
PAVLOVSKIS, OR .
VACCINE, 1995, 13 (01) :22-28
[5]   Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity [J].
Baqar, S ;
Bourgeois, AL ;
Applebee, LA ;
Mourad, AS ;
Kleinosky, MT ;
Mohran, Z ;
Murphy, JR .
INFECTION AND IMMUNITY, 1996, 64 (12) :4933-4939
[6]   MODULATION OF MUCOSAL IMMUNITY AGAINST CAMPYLOBACTER-JEJUNI BY ORALLY-ADMINISTERED CYTOKINES [J].
BAQAR, S ;
PACHECO, ND ;
ROLLWAGEN, FM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2688-2692
[7]   Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice [J].
Baqar, Shahida ;
Applebee, Lisa A. ;
Gilliland, Theron C., Jr. ;
Lee, Lanfong H. ;
Porter, Chad K. ;
Guerry, Patricia .
INFECTION AND IMMUNITY, 2008, 76 (07) :3170-3175
[8]  
Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99
[9]   HUMAN-SERUM ANTIBODY-RESPONSE TO CAMPYLOBACTER-JEJUNI INFECTION AS MEASURED IN AN ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
BLASER, MJ ;
DUNCAN, DJ .
INFECTION AND IMMUNITY, 1984, 44 (02) :292-298
[10]   CAMPYLOBACTER-JEJUNI OUTER-MEMBRANE PROTEINS ARE ANTIGENIC FOR HUMANS [J].
BLASER, MJ ;
HOPKINS, JA ;
VASIL, ML .
INFECTION AND IMMUNITY, 1984, 43 (03) :986-993